Technical Analysis for ARAV - Aravive, Inc.

Grade Last Price % Change Price Change
F 0.04 -13.39% -0.01
ARAV closed down 13.39 percent on Friday, January 26, 2024, on 1.5 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
180 Bearish Setup Bearish Swing Setup 0.00%
Calm After Storm Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Calm After Storm Range Contraction -13.39%
Narrow Range Bar Range Contraction -13.39%
Inside Day Range Contraction -13.39%
Wide Bands Range Expansion -13.39%
Oversold Stochastic Weakness -13.39%

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Aravive, Inc., a clinical stage biotechnology company, focuses on developing therapies for solid tumors and hematologic malignancies. It is developing AVB-S6-500, a GAS6 binding protein and AXL decoy receptor, for the treatment of ovarian cancer, as well as for renal cell carcinoma, acute myeloid leukemia, triple negative breast cancer and pancreatic cancer. The company was formerly known as Versartis, Inc. and changed its name to Aravive, Inc. in October 2018. Aravive, Inc. is based in Houston, Texas.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Solid Tumors Breast Cancer Cell Biology Acute Myeloid Leukemia Ovarian Cancer Treatment Of Breast Cancer Pancreatic Cancer Carcinoma Hematologic Malignancies Bemcentinib Renal Cell Carcinoma Treatment Of Ovarian Cancer Triple Negative Breast Cancer

Is ARAV a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 2.46
52 Week Low 0.0401
Average Volume 2,379,744
200-Day Moving Average 0.70
50-Day Moving Average 0.12
20-Day Moving Average 0.09
10-Day Moving Average 0.07
Average True Range 0.01
RSI (14) 21.88
ADX 30.78
+DI 11.35
-DI 39.70
Chandelier Exit (Long, 3 ATRs) 0.10
Chandelier Exit (Short, 3 ATRs) 0.07
Upper Bollinger Bands 0.16
Lower Bollinger Band 0.03
Percent B (%b) 0.11
BandWidth 146.03
MACD Line -0.02
MACD Signal Line -0.02
MACD Histogram -0.0065
Fundamentals Value
Market Cap 2.95 Million
Num Shares 73.6 Million
EPS -0.76
Price-to-Earnings (P/E) Ratio -0.05
Price-to-Sales 0.42
Price-to-Book 1.73
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.05
Resistance 3 (R3) 0.05 0.05 0.05
Resistance 2 (R2) 0.05 0.05 0.05 0.05
Resistance 1 (R1) 0.04 0.04 0.04 0.04 0.05
Pivot Point 0.04 0.04 0.04 0.04 0.04
Support 1 (S1) 0.04 0.04 0.04 0.04 0.03
Support 2 (S2) 0.04 0.04 0.04 0.03
Support 3 (S3) 0.03 0.04 0.03
Support 4 (S4) 0.03